These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2140201)

  • 21. The N-terminus and a 4,000-MW peptide from the midportion of the N-terminus of the atrial natriuretic factor prohormone each circulate in humans and increase in congestive heart failure.
    Winters CJ; Sallman AL; Baker BJ; Meadows J; Rico DM; Vesely DL
    Circulation; 1989 Sep; 80(3):438-49. PubMed ID: 2527642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in the plasma levels of the N-terminal and C-terminal portions of the prohormone of atrial natriuretic factor during normal pregnancy.
    Merkouris RW; Miller FC; Catanzarite V; Rigg LA; Quirk JG; Vesely DL
    Am J Obstet Gynecol; 1990 Mar; 162(3):859-64. PubMed ID: 2138415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma levels and molecular forms of proatrial natriuretic peptides in healthy subjects and in patients with congestive heart failure.
    Azizi C; Maistre G; Kalotka H; Isnard R; Barthélemy C; Masson F; Pham P; Pousset F; Eurin J; Lechat P; Komajda M; Carayon A
    J Endocrinol; 1996 Jan; 148(1):51-7. PubMed ID: 8568471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of immunoreactive atrial natriuretic factor in healthy subjects and in patients with edema.
    Shenker Y; Sider RS; Ostafin EA; Grekin RJ
    J Clin Invest; 1985 Oct; 76(4):1684-7. PubMed ID: 2932471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Measurement of N-terminal proatrial natriuretic peptide in plasma of cats with and without cardiomyopathy.
    Zimmering TM; Meneses F; Nolte IJ; Simon D
    Am J Vet Res; 2009 Feb; 70(2):216-22. PubMed ID: 19231954
    [TBL] [Abstract][Full Text] [Related]  

  • 26. N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients.
    Franz M; Woloszczuk W; Hörl WH
    Transplantation; 2001 Jul; 72(1):89-94. PubMed ID: 11468540
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
    Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
    Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the association between plasma concentration of N-terminal proatrial natriuretic peptide and outcome in cats with cardiomyopathy.
    Zimmering TM; Hungerbühler S; Meneses F; Nolte I; Simon D
    J Am Vet Med Assoc; 2010 Sep; 237(6):665-72. PubMed ID: 20839988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proatrial natriuretic polypeptide (31-67) in healthy individuals: day-to-day variation and influence of sex and age.
    Hansen JB; Nielsen G; Aarøe J
    Scand J Clin Lab Invest; 1995 Aug; 55(5):447-52. PubMed ID: 8545604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.
    Metry G; Hall C; Wikström B; Källskog V; Hansell P; Danielson B
    Acta Physiol Scand; 2001 Feb; 171(2):117-22. PubMed ID: 11350271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoreactive N-terminal pro-atrial natriuretic peptide in human plasma: plasma levels and comparisons with alpha-human atrial natriuretic peptide in normal subjects, patients with essential hypertension, cardiac transplant and chronic renal failure.
    Buckley MG; Sagnella GA; Markandu ND; Singer DR; MacGregor GA
    Clin Sci (Lond); 1989 Nov; 77(5):573-9. PubMed ID: 2531055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
    Burghardt W; Müller R; Diehl KL; Wernze H
    Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice.
    Wijbenga JA; Balk AH; Boomsma F; Man in 't Veld AJ; Hall C
    Eur Heart J; 1999 Oct; 20(19):1424-8. PubMed ID: 10487803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circadian rhythm of prohormone atrial natriuretic peptides 1-30, 31-67 and 99-126 in man.
    Winters CJ; Sallman AL; Vesely DL
    Chronobiol Int; 1988; 5(4):403-9. PubMed ID: 2976615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
    Wong F; Siu S; Liu P; Blendis LM
    Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay for the N-terminal fragment of the pro-peptide of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide.
    Prontera C; Emdin M; Zucchelli GC; Ripoli A; Passino C; Clerico A
    Clin Chem Lab Med; 2004 Jan; 42(1):37-44. PubMed ID: 15061378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two new hormones: prohormone atrial natriuretic peptides 1-30 and 31-67 circulate in man.
    Winters CJ; Sallman AL; Meadows J; Rico DM; Vesely DL
    Biochem Biophys Res Commun; 1988 Jan; 150(1):231-6. PubMed ID: 2962583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure.
    Hall C; Kjekshus J; Eneroth P; Snapinn S
    Clin Cardiol; 1994 Apr; 17(4):191-5. PubMed ID: 8187369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
    Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnosis of heart failure using urinary natriuretic peptides.
    Ng LL; Geeranavar S; Jennings SC; Loke I; O'Brien RJ
    Clin Sci (Lond); 2004 Feb; 106(2):129-33. PubMed ID: 13678415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.